Decoy Therapeutics Inc
Price
FilingsNewest: 8-K, Material agreementSep 23 →Insiders2 insiders bought $19,750 in 2 open-market buys. 1 insider sold $17, 0 of 2 sales on a 10b5-1 plan.→HoldersVanguard 0.8%Tower Research Capital LLC (TRC) 0.0%UBS 0.0%→Financing →PeersClosest companies: NMTC, SNTI, RNTX→
From the filings
Figures
- Net income
- $10.6Mlast 12 months
- Operating cash flow
- −$6.5Mlast 12 months
- Cash and equivalents
- $8.3Mat the last balance sheet
- Shares outstanding
- 532.0K shareson issue